Topic

Hyderabad pharma

1 article

Granules India Delivers Robust Q4 FY26 with 23% Revenue Surge to ₹1,470.6 Cr
News 30 Apr 2026

Granules India Delivers Robust Q4 FY26 with 23% Revenue Surge to ₹1,470.6 Cr

EBITDA Jumps 40% YoY to ₹352.1 Cr; PAT Rises 33% to ₹201.6 Cr Amid Portfolio Expansion Granules India Ltd., a…